(Q81838768)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15950543%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

title

Type I interferons potently suppress gene expression following gene delivery using liposome(-)DNA complexes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15950543%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

Karen Sellins

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15950543%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Lee Fradkin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15950543%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Denny Liggitt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15950543%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Steven Dow

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15950543%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

publication date

1 September 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15950543%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15950543%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15950543%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15950543%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

451-459

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15950543%20AND%20SRC:MED&resulttype=core&format=json

Cationic liposome-mediated intravenous gene delivery

12 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Systemic gene delivery expands the repertoire of effective antiangiogenic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Cationic liposomes for gene delivery: from biophysics to biological applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Cationic liposome-mediated gene delivery in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Systemic gene expression after intravenous DNA delivery into adult mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Intravenous cytokine gene delivery by lipid-DNA complexes controls the growth of established lung metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid:plasmid DNA complexes in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Increased uptake of liposomal-DNA complexes by lung metastases following intravenous administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Interferons impair early transgene expression by adenovirus-mediated gene transfer in muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Non-replicating Epstein-Barr virus-based plasmids extend gene expression and can improve gene therapy in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Inhibitory effects of tumor necrosis factor-alpha on cationic lipid-mediated gene delivery to airway cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Induction of interferon synthesis and activation of interferon-stimulated genes by liposomal transfection reagents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Toll-like receptor signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Toll-like receptors and dendritic cells: for whom the bug tolls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Neutralization of endogenous interferon-beta increases the efficiency of adenoviral vector-mediated gene transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Immune defence in mice lacking type I and/or type II interferon receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Non-immunostimulatory nonviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Persistent transgene expression following intravenous administration of a liposomal complex: role of interleukin-10-mediated immune suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Quantitative RT-PCR to evaluate in vivo expression of multiple transgenes using a common intron

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Aerosol delivery of lipid:DNA complexes to lungs of rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Improved DNA: liposome complexes for increased systemic delivery and gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Induction of apoptosis in mature T cells by tumour necrosis factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Functional role of type I and type II interferons in antiviral defense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

A role for IFN-alpha beta in virus infection-induced sensitization to endotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.008

10.1016/J.YMTHE.2005.04.008

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15950543%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference